These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23773494)

  • 1. A new left atrial appendage occluder (Lifetech LAmbre Device) for stroke prevention in atrial fibrillation.
    Lam YY
    Cardiovasc Revasc Med; 2013; 14(3):134-6. PubMed ID: 23773494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial appendage closure: First in man with the 4th generation WATCHMAN device.
    Ledwoch J; Franke J; Gonzaga M; Bertog S; Braut A; Hofmann I; Vaskelyte L; Gafoor S; Reddy V; Sievert H
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):787-94. PubMed ID: 26354821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial experience of percutaneous left atrial appendage closure using the LAmbre device for thromboembolic prevention.
    Reinsch N; Ruprecht U; Buchholz J; Edel C; Kälsch H; Neven K
    J Cardiovasc Med (Hagerstown); 2018 Sep; 19(9):491-496. PubMed ID: 29894355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation.
    Ali M; Rigopoulos AG; Mammadov M; Torky A; Auer A; Matiakis M; Abate E; Bakogiannis C; Tzikas S; Bigalke B; Sedding D; Noutsias M
    BMC Cardiovasc Disord; 2020 Feb; 20(1):78. PubMed ID: 32050904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late clinical outcomes of lambre versus amplatzer occluders for left atrial appendage closure.
    Schnupp S; Liu XX; Buffle E; Gloekler S; Mohrez Y; Cheikh-Ibrahim M; Allakkis W; Brachmann J; Park JW; Kleinecke C
    J Cardiovasc Electrophysiol; 2020 Apr; 31(4):934-942. PubMed ID: 32072692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous Left Atrial Appendage Closure With the LAmbre Device for Stroke Prevention in Atrial Fibrillation: A Prospective, Multicenter Clinical Study.
    Huang H; Liu Y; Xu Y; Wang Z; Li Y; Cao K; Zhang S; Yang Y; Yang X; Huang D; Yu B; Su X; Wu L; Huang C
    JACC Cardiovasc Interv; 2017 Nov; 10(21):2188-2194. PubMed ID: 29122133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifetech LAmbre: a new promising and novel device in the interventional stroke prevention.
    Schnupp S; Ajmi I; Brachmann J; Mahnkopf C
    Future Cardiol; 2019 Nov; 15(6):405-410. PubMed ID: 31710249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial appendage occlusion with the WATCHMAN™ for stroke prevention in atrial fibrillation.
    Price MJ
    Rev Cardiovasc Med; 2014; 15(2):142-51. PubMed ID: 25051131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Closure of Left Atrial Appendage With Complex Anatomy Using a LAmbre Device.
    Cruz-Gonzalez I; Moreno-Samos JC; Rodriguez-Collado J; Mo Y; Lam YY; Sanchez PL
    JACC Cardiovasc Interv; 2017 Feb; 10(4):e37-e39. PubMed ID: 28231919
    [No Abstract]   [Full Text] [Related]  

  • 12. LAA occluder device for stroke prevention: Data on WATCHMAN and other LAA occluders.
    Bergmann MW
    Trends Cardiovasc Med; 2017 Aug; 27(6):435-446. PubMed ID: 28461140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience.
    Park JW; Bethencourt A; Sievert H; Santoro G; Meier B; Walsh K; Lopez-Minguez JR; Meerkin D; Valdés M; Ormerod O; Leithäuser B
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):700-6. PubMed ID: 20824765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
    Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
    J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device.
    Alipour A; Wintgens LI; Swaans MJ; Balt JC; Rensing BJ; Boersma LV
    Vasc Health Risk Manag; 2017; 13():81-90. PubMed ID: 28293114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of current and emerging devices for percutaneous left atrial appendage closure.
    Chow DHF; Wong YH; Park JW; Lam YY; De Potter T; Rodés-Cabau J; Asmarats L; Sandri M; Sideris E; McCaw T; Lee RJ; Sievert H; Søndergaard L; De Backer O
    Trends Cardiovasc Med; 2019 May; 29(4):228-236. PubMed ID: 30205924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial appendage orifice diameter measured with trans-esophageal echocardiography is independently related with peri-device leakage after Watchman device implantation.
    Chen YY; Zhang YH; Chen X; Huang WP; Xu B; Su X; Chen YH
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1831-1839. PubMed ID: 31321654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a Novel Septal Occluder Device for Left Atrial Appendage Closure in Patients With Postsurgical and Postlariat Leaks or Anatomies Unsuitable for Conventional Percutaneous Occlusion.
    Della Rocca DG; Horton RP; Tarantino N; Van Niekerk CJ; Trivedi C; Chen Q; Mohanty S; Anannab A; Murtaza G; Akella K; Gianni C; Bassiouny M; Ahmadian-Tehrani A; Al-Ahmad A; Burkhardt JD; Natale VN; Price M; Gallinghouse GJ; Gibson DN; Lakkireddy D; Di Biase L; Natale A
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009227. PubMed ID: 32942913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of percutaneous left atrial appendage closure using a novel LAmbre occluder in patients with atrial fibrillation: Initial results from a prospective cohort registry study.
    Chen S; Schmidt B; Bordignon S; Bologna F; Nagase T; Tsianakas N; Perrotta L; Chun KRJ
    J Cardiovasc Electrophysiol; 2018 Feb; 29(2):291-297. PubMed ID: 29149516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.